Alpha Tau Medical Ltd (DRTS)
Alpha Tau Medical Ltd operates in the Biotechnology industry of the Healthcare sector, headquartered in Jerusalem, JM, IL. The stock last traded at $14.54, down 1.56% on the session, giving a market capitalisation of $1.31B. On trailing twelve-month figures it carries a trailing P/E of -13.98, a net margin of 0.0%. Its beta of 1.21 implies it has historically moved more than the broad market.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Alpha Tau Medical Ltd is most often compared with the following Healthcare names: